March 4, 2020 / 10:21 PM / a month ago

BRIEF-Soleno Therapeutics Reports Q4 Loss Per Share Of $0.36

March 4 (Reuters) - Soleno Therapeutics Inc:

* SOLENO THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.36

* Q4 EARNINGS PER SHARE ESTIMATE $-0.16 — REFINITIV IBES DATA

* AS OF DECEMBER 31, 2019, SOLENO HAD CASH AND CASH EQUIVALENTS OF APPROXIMATELY $20.7 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below